APA (7th ed.) Citation

Rioux, J. D., Boucher, G., Forest, A., Bouchard, B., Coderre, L., Daneault, C., . . . Rosiers, C. D. (2025). Serum proteomic and metabolomic analyses from patients with IBD identify biological pathways associated with treatment success with anti‐integrin therapy. Wiley. https://doi.org/10.1111/imcb.70039

Chicago Style (17th ed.) Citation

Rioux, John D., et al. Serum Proteomic and Metabolomic Analyses from Patients with IBD Identify Biological Pathways Associated with Treatment Success with Anti‐integrin Therapy. Wiley, 2025. https://doi.org/10.1111/imcb.70039.

MLA (9th ed.) Citation

Rioux, John D., et al. Serum Proteomic and Metabolomic Analyses from Patients with IBD Identify Biological Pathways Associated with Treatment Success with Anti‐integrin Therapy. Wiley, 2025. https://doi.org/10.1111/imcb.70039.